findmyKOL
Clinical trialNCT02950064UnknownPhase 1Interventional

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

SponsorPlacon TherapeuticsEnrollment95Breast NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsProstatic Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Placon Therapeutics Clinical Trial Site

    Sarasota, Florida, United States

  • Placon Therapeutics Clinical Trial Site

    Boston, Massachusetts, United States

  • Placon Therapeutics Clinical Trial Site

    Boston, Massachusetts, United States

  • Placon Therapeutics Clinical Trial Site

    St Louis, Missouri, United States

  • Placon Therapeutics Clinical Trial Site

    Cleveland, Ohio, United States

  • Placon Therapeutics Clinical Trial Site

    Oklahoma City, Oklahoma, United States

  • Placon Therapeutics Clinical Trial Site

    Nashville, Tennessee, United States

  • Placon Therapeutics Clinical Trial Site

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2016
Primary completion
30 Apr 2020
Completion
31 Aug 2020
Last update posted
14 Jan 2019
Registered enrollment
95
Registry id
NCT02950064

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.